Rasagiline

🧮 Dose calculator

Parkinson's disease · Regimen source: FDA Rasagiline · 2.1

• • With ciprofloxacin or other CYP1A2 inhibitors and in mild hepatic impairment: 0.5 mg; not for moderate or severe hepatic impairment. FDA Rasagiline · 2.2FDA Rasagiline · 2.3

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Rasagiline · 8.1

  “Risk Summary There are no adequate data on the developmental risks associated with the use of rasagiline in pregnant women.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Rasagiline · 8.2

  “Risk Summary There are no data on the presence of rasagiline in human milk or the effects on the breastfed infant.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Rasagiline · 8.4

  “The safety and effectiveness in pediatric patients have not been established.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Rasagiline · 8.5

  “Approximately half of patients in clinical trials were 65 years and over.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.